Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis
Clinical trial NCT05342428 · COMPLETED
Trial details
- NCT number
- NCT05342428
- Sponsor
- Hangzhou Highlightll Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2023-08-30
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.